6DAG | Oxidoreductase Oxidoreductase Inhibitor | date | May 01, 2018 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Human Cyp3a4 Bound To An Inhibitor | ||||||||||||||
authors | I.F.Sevrioukova | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Cytochrome P450 3a4 Chain: A Fragment: Residues 23-503 Synonym: 1,8-Cineole 2-Exo-Monooxygenase,Albendazole Monoox Albendazole Sulfoxidase,Cypiiia3,Cypiiia4,Cholesterol 25-Hy Cytochrome P450 3a3,Cytochrome P450 Hlp,Cytochrome P450 Nf- Cytochrome P450-Pcn1,Nifedipine Oxidase,Quinine 3-Monooxyge Taurochenodeoxycholate 6-Alpha-Hydroxylase; Ec: 1.14.14.-,1.14.14.56,1.14.14.55 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Cyp3a4, Cyp3a3 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: I 2 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.80 Å | ||||||||||||
ligand | G0Y, HEM | enzyme | Oxidoreductase E.C.1.14.14 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Structure-activity relationships of rationally designed ritonavir analogs: Impact of side-group stereochemistry, head-group spacing, and backbone composition on the interaction with CYP3A4., Samuels ER, Sevrioukova I, Biochemistry. 2019 Mar 26. doi: 10.1021/acs.biochem.9b00156. PMID:30912932 |
Data retrieval |
View 6DAG in 3D |
Visual 3D analysis of 6DAG |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6DAG |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |